Research Reagent Opportunities

Research at Oxford often results in the creation of very specific reagents that are particularly useful in specialised areas of study such as diagnostic indicators, screening tools or molecular markers. Reagents@Isis offers research reagents for sale such as hybridomas, cell lines and other materials, from life and physical sciences, which have been created by Oxford University researchers.

If you wish to acquire reagents/materials from Oxford for purely non-commercial research evaluation purposes then the University can supply those rights under a Materials Transfer Agreement.

If you are a researcher at Oxford and would like to find out more about making your reagents available for purchase then please click here.

The reagents currently available from Isis are listed in the following categories:

• Life Science research catalogue (e.g. hybridomas, cell lines and other materials)
• Fullerenes
• Screening Libraries of compounds from the Department of Chemistry and Pharmacology for agrochemical and drug discovery applications

The availability of research reagents from Isis is constantly changing, so it is recommended that you contact Isis Innovation directly at reagents@isis.ox.ac.uk with your specific requirements.

 

The information presented here on these pages has been provided by the scientists and academics who have created the reagents. As far as Isis is able to establish this information is accurate but no representation is given as to its accuracy or completeness. It is the responsibility of the customer to determine the suitability for any purpose of the reagents and Isis shall not be liable for any claims, losses, liabilities, expenses or damages arising from any use of the materials. Nothing on these pages will form part of any contract or licence nor be regarded as a warranty or representation in relation to the products. Any supply would be subject to the terms and conditions of a separate agreement. Isis makes no representation that any item in this catalogue is not subject to third party intellectual property rights.